Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217873 · ClinicalTrials.gov registry record · Phase 2
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
A Phase 2 study of Spinal Fusion and Iron-deficiency, sponsored by Columbia University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07217873: Recruiting Phase 2 study of Spinal Fusion and Iron-deficiency, sponsored by Columbia University.
NCT07217873 is a Phase 2 study of Spinal Fusion and Iron-deficiency that is actively recruiting participants, run by Columbia University. The registered enrollment target is 120 participants, below the 477-participant average among 19 other Spinal Fusion trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217873, a Phase 2 study of Spinal Fusion and Iron-deficiency, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is a randomized controlled trial of preoperative intravenous iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in this vulnerable population. Building evidence for patient blood management interventions such as iron supplementation is vital to ensuring high quality care of surgical patients and may reduce unnecessary transfusions amid recent blood shortages.
Primary Outcome
The patients that received a red blood cell transfusion either during procedure or postoperatively during their surgical hospitalization will be tallied.
Conditions Studied
Interventions
- DRUG Normal Saline (Placebo)
- DRUG Ferric carboxymaltose IV
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2027-10-31 |
| Phase | Phase 2 |
What NCT07217873 shows while recruiting
NCT07217873 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 477-participant average among 19 other Spinal Fusion trials with a reported enrollment target (75% lower).
The record links to 7 conditions, with Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline (Placebo) is the first listed.
NCT07217873 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07217873 about?
NCT07217873 is a clinical study titled "IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study". Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is ...
What is the current status of trial NCT07217873?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-11-21. Estimated completion is 2027-10-31.
What conditions does trial NCT07217873 study?
This clinical trial studies the following conditions: Spinal Fusion, Iron-deficiency, Surgery--Complications, Scoliosis Correction, Transfusion Blood.
What interventions are being tested in trial NCT07217873?
The interventions under investigation include: Normal Saline (Placebo) (DRUG), Ferric carboxymaltose IV (DRUG).
Who is sponsoring clinical trial NCT07217873?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217873 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07217873's enrollment target sits among peer trials
120 9th of 19 higher than 11 of 19 other Spinal Fusion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Fusion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI